Navigation Links
Bone Biologics Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Date:9/16/2013

NEW YORK, Sept. 16, 2013 /PRNewswire/ -- Bone Biologics today announced its September 12th RetailInvestorConferences.com presentation is now available for on-demand viewing.  

Bone Biologics's presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks.

LINK:    www.retailinvestorconferences.com > click on the red "register/ watch event now" button

About Bone Biologics:

Bone Biologics was founded by University of California professors in collaboration with an Osaka University professor and a USC Surgeon in 2004.  Bone Biologics is a privately-held company with proprietary, patented technology that has been clinically proven in non-human primate models to facilitate bone growth. The company is currently focused on bone regeneration in spinal fusion using its recombinant human protein, known as UCB-1 (or Nell-1). UCB-1 is an osteoinductive orthobiologic: a recombinant protein that provides control over bone regeneration. This patent protected technology has been exclusively licensed to Bone Biologics from UCLA.

About RetailInvestorConferences.com:

Since 2010, RetailInvestorConferences.com has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.


'/>"/>
SOURCE Bone Biologics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Advanced Biologics Opens New and Expanded Headquarters in Carlsbad, California
2. PUR Biologics’ Novel Orthopedic Developments Supported by Two New US Patents
3. Synthetic Biologics to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
4. KBI Biopharma Selects Freeslate’s Biologics Formulation System for Early and Late Stage Drug Development
5. Freeslate’s Biologics Formulation System Selected by Sanofi Pasteur to Improve Efficiency of Formulation Development
6. BiologicsMD, Inc. Announces Issuance of First U.S. Patent for PTH-CBD™
7. Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
8. Synthetic Biologics to Report Second Quarter 2013 Financial Results
9. Synthetic Biologics Initiates Manufacturing Process for C. difficile Infectious Disease Program
10. Synthetic Biologics to Present at OneMedForum New York 2013
11. Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... -- Novan, Inc. today announced that Director Robert A. Ingram ... Novan. In addition, Robert Keegan has been appointed to ... . --> North Carolina . ... total of $32.8 million of net proceeds in a private Mezzanine ... throughout the Research Triangle area of North Carolina ...
(Date:2/8/2016)... ... ... Information Management Services ( IMS ) is pleased to announce a major ... foundation and is so significant it was endowed with a new name, BSI Engage. ... results, a streamlined layout and a more intuitive format for navigating the system. ...
(Date:2/8/2016)... (NYSE MKT: NNVC) (the "Company"), a nanomedicine company developing anti-viral drugs, ... present information about the company,s programs at the BIOCEO conference today ... City . --> --> ... Registered attendees can request a one on one meeting through the conference ... --> New York City . --> ...
(Date:2/8/2016)... 8, 2016 --> ... the "Company"), the ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today ... Chlamydia trachomatis (CT) test to be launched on the Company,s ... (98/79/EC), the CT test is now cleared for sale within ... The launch of the io® CT test signals a ...
Breaking Biology Technology:
(Date:1/21/2016)... , January 21, 2016 ... a new market research report "Emotion Detection and Recognition ... Software Tools (Facial Expression, Voice Recognition and Others), ... Global forecast to 2020", published by MarketsandMarkets, the ... to reach USD 22.65 Billion by 2020, at ...
(Date:1/20/2016)... 2016   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce the attainment of ... the result of the company,s laser focus on (and ... , it,s comprehensive, easy-to-use and highly affordable cloud-based technology ... Key MedNet growth achievements in 2015 include: ...
(Date:1/18/2016)... 2016  Extenua Inc., a pioneering developer of ... and access of ubiquitous on-premise and cloud storage, today ... Cyber.  ... C4ISR and Cyber initiatives in support of National ... technology solutions," said Steve Visconti , Extenua ...
Breaking Biology News(10 mins):